jump to navigation
jump to content
Search in Articles and Documents
generate
PDF
-Version of this page
1:
H
ome
(ALT-H)
2:
H
M
A Joint
(ALT-M)
3:
H
u
man Medicines
(ALT-U)
3.1:
H
e
ads of Agencies
(ALT-E)
3.2:
C
MDh
(ALT-C)
3.3:
M
R
I Product Index
(ALT-R)
3.4:
D
i
rectory
(ALT-I)
4:
V
eterinary Medicines
(ALT-V)
You are here:
Human Medicines
>
CMDh
>
CMD subgroups / working groups
> Joint CMDh/
PhVWP
WG
3.2.1:
Ab
o
ut CMDh
(ALT-O)
3.2.2:
S
tatistics
(ALT-S)
3.2.3:
P
ress Releases
(ALT-P)
3.2.4:
Procedura
l
Guidance
(ALT-L)
3.2.5:
CMDh-Referrals
3.2.6:
Produc
t
Information
(ALT-T)
3.2.7:
Advice from CMDh
3.2.8:
Templates
3.2.9:
CMD sub
g
roups / working groups
(ALT-G)
3.2.9.1:
W
orking Group on Active Substance Master File Procedures
(ALT-W)
3.2.9.2:
Wor
k
ing Party on Future of the CMDh
(ALT-K)
3.2.9.3:
Subgroup o
n
Paediatric Regulation
(ALT-N)
3.2.9.4:
Subgroup on Variation Regulation
3.2.9.5:
Subgroup on Harmonisation of SmPCs
3.2.9.6:
J
oint CMDh/
PhVWP
WG
(ALT-J)
3.2.9.7:
CTS Working Group
3.2.9.8:
Joint CMDh/GCP Inspectors Subgroup
3.2.10:
Paediatric Regulation
3.2.11:
Q
uestions & Answers
(ALT-Q)
3.2.12:
Contact Form
3.2.13:
Contact Points
3.2.14:
What's new histor
y
(ALT-Y)
Joint CMDh/
PhVWP
WG
Mandate for the Joint CMDh/
PhVWP
WG
(July 2009)
Best Practice Guide on communication and implementation of safety information
(June 2010)
